Adipose-Derived Stem Cells: Current Applications and Future Directions
A special issue of Cells (ISSN 2073-4409). This special issue belongs to the section "Stem Cells".
Deadline for manuscript submissions: 20 January 2025 | Viewed by 174
Special Issue Editor
Interests: adipose-derived stem cells; mRNA decay; noncoding RNA; RNA bindings; transcriptome analysis
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Cultured adipose-derived stem cells have many advantages over other mesenchymal stem cells and have demonstrated therapeutic efficacy in a variety of areas, including plastic surgery. However, they may not be the perfect cell source of therapy at this time.
Therefore, there is a need to construct new adipose-derived stem cell systems with improved cell culture methods and genetic manipulation. For example, the formation of spheroids and sheets, an improvement in culture media, and the development of new culture substrates are expected to enhance therapeutic outcomes. Moreover, attempts are being made to improve therapeutic efficacy by increasing the secretory capacity of various factors using genetic recombination technology. In addition to the above efforts, this Special Issue aims to include reports of novel therapeutic methods using ADSCs, utilization and purification methods of exosomes, and other cellular secreted products. Based on the above, we aim to provide an argument in this Special Issue for the future use of next-generation adipose-derived stem cells.
Prof. Dr. Yasuhito Ishigaki
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cell therapy
- regenerative medicine
- adipose-derived stem cells (ADSCs)
- exosome
- cytokine
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
